Pharmaceutical Technology Europe E-Alert

Pharmaceutical Technology E-Alert: Having trouble viewing this e-mail? Click here.	You are subscribed to %%list.name%% as %%emailaddr%%. Click here to unsubscribe or edit your member profile.

BLOG

EVENT CALENDAR

COLUMNS

WHITE PAPERS

THE MAGAZINE

21 May 2010

IN THIS ISSUE
• Pfizer job cuts
• FDA targets bad ads
• Reader survey
• Pharma's critical situation



Pfizer to axe 6000 jobs Pfizer has begun implementing the first phase of its Plant Network Strategy, which will result in the loss of approximately 6000 jobs over the next several years. More...

FDA launches Bad Ad program The FDA has launched a program designed to “educate healthcare providers about their role in ensuring that prescription drug advertising and promotion is truthful". More...

Take part in PTE's short reader survey What are we getting right and what can we improve upon? Give your opinion of Pharmaceutical Technology Europe by taking part in a short survey and be in with the chance of winning an iPod Touch! More...

Patent cliff pushes pharma into critical situation More acquisitions are expected as the patent cliff pushes the pharma industry into a critical phase, with many executives believing that the industry will be unable to innovate sufficiently from within to replace blockbuster drugs. More...

Ten principles on counterfeit medicines The International Federation of Pharmaceutical Manufacturers and Associations has published its Ten Principles on Counterfeit Medicines, which define counterfeit medicines, describe the threats they pose and suggest ways to prevent counterfeit drugs from reaching patients. More...

*Join PTE* on LinkedIn!** Join Pharmaceutical Technology Europe's group on LinkedIn. More...

Product Profile

Agilent

Automatic and reliable detection and quantification of low concentrated protein impurities down to 0.05% and below with the Agilent 2100 Bioanalyzer!

Product Profile

Agilent

Poroshell 120 HPLC columns give you speed and resolution like a sub-2 µm column with up to 50% less back pressure – usually less than 400 bar. And they have standard frits, so they are more forgiving for dirty samples.

Product Profile

Watson Marlow

New weldable pump tube, PureWeld XL from Watson-Marlow, a new weldable and ADCF (animal-derived contents free) tube for use in bio-pharmaceutical processes, provides users with secure joins that allow for a connector-free fluid path. PureWeld demonstrates very low internal spallation and gives long tube life in peristaltic pump applications.

Event profile

9th Annual World Drug Manufacturing Summit

November 30 - December 2, 2010
Berlin, Germany

World Drug Manufacturing 2010 will debate the latest industry challenges occurring throughout small molecule and biologic manufacturing. The industry is facing increasing pressure to reduce costs, in order to remain competitive against generics. It is therefore more important than ever that companies reduce waste, streamline processes and increase their global presence.

Event profile

Chemspec 2010

June 9-10, 2010
Messe Berlin, Germany

After the success of Chemspec Europe in Barcelona, Berlin is a natural choice as the destination for Chemspec Europe 2010. Germany is at the heart of the European fine and speciality chemicals market and the third largest chemical producer in the world making it an ideal destination for Chemspec Europe to celebrate its 25th anniversary…

Key Topic Updates

Latest blog posts

New head of NCI faces challenges

Is healthcare reform socialism?

Bringing online pharmacies in line

More blog posts

PTE Digital

Bioanalysis: hurdles and hopes

Predicting new promise in particle size analysis

Sample analysis: automation is crucial

Read the full issue

June events

CPhI China (2–4 June | China)

Packology (8–11 June | Italy)

Chemspec Europe (9–10 June | Germany)

More events

During tablet manufacture, what is the most common problem encountered by your company?

■		Poor weight uniformity 12%
■		Poor content uniformity 15%
■		Poor formulation design 34%
■		Inadequate equipment maintenance 14%
■		Incorrect equipment operation 15%
■		Other 10%

This week we would like to know...

To encourage innovation in excipients, do you think FDA should review novel excipients outside of a new drug application?

Contact Us
Click here to contact editorial.

Click here to contact sales.

You are subscribed to %%list.name%% as %%emailaddr%%. Click here to unsubscribe or edit your member profile.

To ensure delivery to your inbox, please add us to your address book. If you need help doing this, click here.

Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact
information available to third parties for marketing purposes, please contact us by emailing magazines@superfill.com or by mail at Advanstar Communications Inc., Advanstar House, Park West, Sealand Road, Chester, CH1 4RN United Kingdom